August 1, 2017
Onco360 announces selection to highly limited pharmacy network for NERLYNX.
May 2, 2016
Onco360 is a Silver Sponsor at this years Asembia Specialty Pharmacy Summit; Also Featured During Two Panel Sessions
April 14, 2016
Onco360 announces selection to highly limited pharmacy network for VENCLEXTA.
March 22, 2016
Limited distribution medication XALKORI (crizotinib) receives approval for certain NSCLC patients.
March 7, 2016
Limited distribution breast cancer medication IBRANCE approved for additional indication.
February 9, 2016
Imatinib Mesylate (generic Gleevec) was recently approved for 7 indications.
January 25, 2016
Combination therapy receives accelerated approval for new indication. OPDIVO also receives additional indication as a single therapy.
October 7, 2015
Onco360 Selected for Lonsurf Limited Distribution Pharmacy Network
September 25, 2015
Onco360 will be exhibiting at NASP's Annual Meeting
June 16, 2015
Onco360 Receives URAC Specialty Pharmacy Accreditation...